**Chapter 5**

*Pathogenic Bacteria*

2013;**56**:1310-1318

2006;**58**:848-852

Asia. Clinical Infectious Diseases.

[35] Bergen PJ, Landersdorfer CB, Zhang J, et al. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: What is new? Diagnostic Microbiology and Infectious Disease. 2012;**74**:213-223

[36] Ellington MJ, Livermore DM, Pitt TL, Hall LM, Woodford N. Mutators among CTX-M β-lactamase-producing

*Escherichia coli* and risk for the emergence of fosfomycin resistance. Journal of Antimicrobial Chemotherapy.

**70**
